nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—GRIN1—Memantine—Alzheimer's disease	0.406	0.543	CbGbCtD
Orphenadrine—GRIN3A—Memantine—Alzheimer's disease	0.246	0.329	CbGbCtD
Orphenadrine—CYP2B6—Memantine—Alzheimer's disease	0.0472	0.0631	CbGbCtD
Orphenadrine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0209	0.028	CbGbCtD
Orphenadrine—CYP3A4—Donepezil—Alzheimer's disease	0.0167	0.0224	CbGbCtD
Orphenadrine—CYP3A4—Galantamine—Alzheimer's disease	0.0108	0.0144	CbGbCtD
Orphenadrine—GRIN1—telencephalic ventricle—Alzheimer's disease	0.00839	0.12	CbGeAlD
Orphenadrine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00656	0.0938	CbGeAlD
Orphenadrine—GRIN2D—forebrain—Alzheimer's disease	0.00246	0.0351	CbGeAlD
Orphenadrine—GRIN3A—forebrain—Alzheimer's disease	0.00231	0.033	CbGeAlD
Orphenadrine—GRIN2D—telencephalon—Alzheimer's disease	0.00226	0.0323	CbGeAlD
Orphenadrine—GRIN1—forebrain—Alzheimer's disease	0.00219	0.0313	CbGeAlD
Orphenadrine—GRIN3A—telencephalon—Alzheimer's disease	0.00212	0.0304	CbGeAlD
Orphenadrine—GRIN1—telencephalon—Alzheimer's disease	0.00201	0.0288	CbGeAlD
Orphenadrine—SCN1A—forebrain—Alzheimer's disease	0.00148	0.0211	CbGeAlD
Orphenadrine—SCN1A—telencephalon—Alzheimer's disease	0.00136	0.0194	CbGeAlD
Orphenadrine—GRIN2D—nervous system—Alzheimer's disease	0.00133	0.0191	CbGeAlD
Orphenadrine—SCN10A—forebrain—Alzheimer's disease	0.00131	0.0187	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—Alzheimer's disease	0.00128	0.0184	CbGeAlD
Orphenadrine—GRIN2D—cerebellum—Alzheimer's disease	0.00126	0.0179	CbGeAlD
Orphenadrine—GRIN3A—nervous system—Alzheimer's disease	0.00125	0.0179	CbGeAlD
Orphenadrine—Hallucination—Galantamine—Alzheimer's disease	0.00124	0.0257	CcSEcCtD
Orphenadrine—GRIN3A—central nervous system—Alzheimer's disease	0.00121	0.0173	CbGeAlD
Orphenadrine—SCN10A—telencephalon—Alzheimer's disease	0.0012	0.0172	CbGeAlD
Orphenadrine—GRIN1—nervous system—Alzheimer's disease	0.00119	0.017	CbGeAlD
Orphenadrine—GRIN1—central nervous system—Alzheimer's disease	0.00114	0.0164	CbGeAlD
Orphenadrine—GRIN1—cerebellum—Alzheimer's disease	0.00112	0.016	CbGeAlD
Orphenadrine—Tension—Galantamine—Alzheimer's disease	0.00107	0.022	CcSEcCtD
Orphenadrine—Vision blurred—Galantamine—Alzheimer's disease	0.00103	0.0212	CcSEcCtD
Orphenadrine—GRIN2D—brain—Alzheimer's disease	0.00102	0.0146	CbGeAlD
Orphenadrine—Tremor—Galantamine—Alzheimer's disease	0.00102	0.021	CcSEcCtD
Orphenadrine—CHRM2—forebrain—Alzheimer's disease	0.00101	0.0144	CbGeAlD
Orphenadrine—Agitation—Galantamine—Alzheimer's disease	0.001	0.0206	CcSEcCtD
Orphenadrine—Hallucination—Donepezil—Alzheimer's disease	0.000964	0.0199	CcSEcCtD
Orphenadrine—Palpitations—Galantamine—Alzheimer's disease	0.000961	0.0198	CcSEcCtD
Orphenadrine—GRIN3A—brain—Alzheimer's disease	0.000958	0.0137	CbGeAlD
Orphenadrine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000958	0.0198	CcSEcCtD
Orphenadrine—CHRM2—telencephalon—Alzheimer's disease	0.000929	0.0133	CbGeAlD
Orphenadrine—GRIN1—brain—Alzheimer's disease	0.000909	0.013	CbGeAlD
Orphenadrine—Confusional state—Galantamine—Alzheimer's disease	0.000895	0.0185	CcSEcCtD
Orphenadrine—Hallucination—Memantine—Alzheimer's disease	0.000875	0.0181	CcSEcCtD
Orphenadrine—Tachycardia—Galantamine—Alzheimer's disease	0.000866	0.0179	CcSEcCtD
Orphenadrine—Skin disorder—Galantamine—Alzheimer's disease	0.000862	0.0178	CcSEcCtD
Orphenadrine—Hallucination—Rivastigmine—Alzheimer's disease	0.000856	0.0177	CcSEcCtD
Orphenadrine—SCN4A—nervous system—Alzheimer's disease	0.000831	0.0119	CbGeAlD
Orphenadrine—Tension—Donepezil—Alzheimer's disease	0.000827	0.0171	CcSEcCtD
Orphenadrine—SLC6A2—forebrain—Alzheimer's disease	0.000813	0.0116	CbGeAlD
Orphenadrine—SCN1A—nervous system—Alzheimer's disease	0.000801	0.0114	CbGeAlD
Orphenadrine—SCN4A—central nervous system—Alzheimer's disease	0.0008	0.0114	CbGeAlD
Orphenadrine—Vision blurred—Donepezil—Alzheimer's disease	0.000794	0.0164	CcSEcCtD
Orphenadrine—Tremor—Donepezil—Alzheimer's disease	0.00079	0.0163	CcSEcCtD
Orphenadrine—Somnolence—Galantamine—Alzheimer's disease	0.000789	0.0163	CcSEcCtD
Orphenadrine—Agitation—Donepezil—Alzheimer's disease	0.000775	0.016	CcSEcCtD
Orphenadrine—SCN1A—central nervous system—Alzheimer's disease	0.000771	0.011	CbGeAlD
Orphenadrine—Constipation—Galantamine—Alzheimer's disease	0.000759	0.0157	CcSEcCtD
Orphenadrine—SCN1A—cerebellum—Alzheimer's disease	0.000754	0.0108	CbGeAlD
Orphenadrine—Tension—Memantine—Alzheimer's disease	0.000751	0.0155	CcSEcCtD
Orphenadrine—SLC6A2—telencephalon—Alzheimer's disease	0.000747	0.0107	CbGeAlD
Orphenadrine—Tension—Rivastigmine—Alzheimer's disease	0.000735	0.0152	CcSEcCtD
Orphenadrine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000732	0.0151	CcSEcCtD
Orphenadrine—KCNH2—forebrain—Alzheimer's disease	0.00073	0.0104	CbGeAlD
Orphenadrine—Vision blurred—Memantine—Alzheimer's disease	0.000721	0.0149	CcSEcCtD
Orphenadrine—Tremor—Memantine—Alzheimer's disease	0.000717	0.0148	CcSEcCtD
Orphenadrine—SCN9A—brain—Alzheimer's disease	0.000712	0.0102	CbGeAlD
Orphenadrine—SCN10A—nervous system—Alzheimer's disease	0.000709	0.0101	CbGeAlD
Orphenadrine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000706	0.0146	CcSEcCtD
Orphenadrine—Agitation—Memantine—Alzheimer's disease	0.000703	0.0145	CcSEcCtD
Orphenadrine—Tremor—Rivastigmine—Alzheimer's disease	0.000702	0.0145	CcSEcCtD
Orphenadrine—Confusional state—Donepezil—Alzheimer's disease	0.000694	0.0143	CcSEcCtD
Orphenadrine—Agitation—Rivastigmine—Alzheimer's disease	0.000688	0.0142	CcSEcCtD
Orphenadrine—SCN10A—central nervous system—Alzheimer's disease	0.000682	0.00975	CbGeAlD
Orphenadrine—Palpitations—Memantine—Alzheimer's disease	0.000676	0.014	CcSEcCtD
Orphenadrine—KCNH2—telencephalon—Alzheimer's disease	0.000671	0.00959	CbGeAlD
Orphenadrine—Palpitations—Rivastigmine—Alzheimer's disease	0.000662	0.0137	CcSEcCtD
Orphenadrine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000654	0.0135	CcSEcCtD
Orphenadrine—SCN5A—nervous system—Alzheimer's disease	0.000644	0.00921	CbGeAlD
Orphenadrine—Asthenia—Galantamine—Alzheimer's disease	0.000637	0.0131	CcSEcCtD
Orphenadrine—SCN4A—brain—Alzheimer's disease	0.000635	0.00907	CbGeAlD
Orphenadrine—Confusional state—Memantine—Alzheimer's disease	0.00063	0.013	CcSEcCtD
Orphenadrine—SCN5A—central nervous system—Alzheimer's disease	0.00062	0.00886	CbGeAlD
Orphenadrine—Confusional state—Rivastigmine—Alzheimer's disease	0.000616	0.0127	CcSEcCtD
Orphenadrine—SCN1A—brain—Alzheimer's disease	0.000612	0.00875	CbGeAlD
Orphenadrine—Somnolence—Donepezil—Alzheimer's disease	0.000612	0.0126	CcSEcCtD
Orphenadrine—Tachycardia—Memantine—Alzheimer's disease	0.00061	0.0126	CcSEcCtD
Orphenadrine—Skin disorder—Memantine—Alzheimer's disease	0.000607	0.0125	CcSEcCtD
Orphenadrine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000596	0.0123	CcSEcCtD
Orphenadrine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000594	0.0122	CcSEcCtD
Orphenadrine—Constipation—Donepezil—Alzheimer's disease	0.000588	0.0121	CcSEcCtD
Orphenadrine—Dizziness—Galantamine—Alzheimer's disease	0.000587	0.0121	CcSEcCtD
Orphenadrine—HRH1—forebrain—Alzheimer's disease	0.000585	0.00836	CbGeAlD
Orphenadrine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000567	0.0117	CcSEcCtD
Orphenadrine—Vomiting—Galantamine—Alzheimer's disease	0.000564	0.0116	CcSEcCtD
Orphenadrine—Headache—Galantamine—Alzheimer's disease	0.000556	0.0115	CcSEcCtD
Orphenadrine—Somnolence—Memantine—Alzheimer's disease	0.000555	0.0115	CcSEcCtD
Orphenadrine—CHRM2—nervous system—Alzheimer's disease	0.000548	0.00784	CbGeAlD
Orphenadrine—Urticaria—Donepezil—Alzheimer's disease	0.000547	0.0113	CcSEcCtD
Orphenadrine—Somnolence—Rivastigmine—Alzheimer's disease	0.000543	0.0112	CcSEcCtD
Orphenadrine—SCN10A—brain—Alzheimer's disease	0.000542	0.00774	CbGeAlD
Orphenadrine—HRH1—telencephalon—Alzheimer's disease	0.000538	0.00769	CbGeAlD
Orphenadrine—Constipation—Memantine—Alzheimer's disease	0.000534	0.011	CcSEcCtD
Orphenadrine—CHRM2—central nervous system—Alzheimer's disease	0.000528	0.00755	CbGeAlD
Orphenadrine—Nausea—Galantamine—Alzheimer's disease	0.000527	0.0109	CcSEcCtD
Orphenadrine—Constipation—Rivastigmine—Alzheimer's disease	0.000523	0.0108	CcSEcCtD
Orphenadrine—CYP2E1—telencephalon—Alzheimer's disease	0.000517	0.00739	CbGeAlD
Orphenadrine—Feeling abnormal—Memantine—Alzheimer's disease	0.000515	0.0106	CcSEcCtD
Orphenadrine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000507	0.0105	CcSEcCtD
Orphenadrine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000504	0.0104	CcSEcCtD
Orphenadrine—Urticaria—Memantine—Alzheimer's disease	0.000496	0.0102	CcSEcCtD
Orphenadrine—Asthenia—Donepezil—Alzheimer's disease	0.000494	0.0102	CcSEcCtD
Orphenadrine—SCN5A—brain—Alzheimer's disease	0.000492	0.00704	CbGeAlD
Orphenadrine—Pruritus—Donepezil—Alzheimer's disease	0.000487	0.01	CcSEcCtD
Orphenadrine—Urticaria—Rivastigmine—Alzheimer's disease	0.000485	0.01	CcSEcCtD
Orphenadrine—Hypersensitivity—Memantine—Alzheimer's disease	0.00046	0.0095	CcSEcCtD
Orphenadrine—Dizziness—Donepezil—Alzheimer's disease	0.000455	0.00939	CcSEcCtD
Orphenadrine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00045	0.00929	CcSEcCtD
Orphenadrine—Asthenia—Memantine—Alzheimer's disease	0.000448	0.00925	CcSEcCtD
Orphenadrine—Aprindine—CALM1—Alzheimer's disease	0.000444	0.0773	CrCbGaD
Orphenadrine—Pruritus—Memantine—Alzheimer's disease	0.000442	0.00912	CcSEcCtD
Orphenadrine—SLC6A2—nervous system—Alzheimer's disease	0.000441	0.00631	CbGeAlD
Orphenadrine—Asthenia—Rivastigmine—Alzheimer's disease	0.000438	0.00905	CcSEcCtD
Orphenadrine—Vomiting—Donepezil—Alzheimer's disease	0.000437	0.00903	CcSEcCtD
Orphenadrine—Dimetacrine—ACHE—Alzheimer's disease	0.000436	0.0758	CrCbGaD
Orphenadrine—Pruritus—Rivastigmine—Alzheimer's disease	0.000432	0.00892	CcSEcCtD
Orphenadrine—Headache—Donepezil—Alzheimer's disease	0.000431	0.00889	CcSEcCtD
Orphenadrine—SLC6A2—central nervous system—Alzheimer's disease	0.000425	0.00607	CbGeAlD
Orphenadrine—CHRM2—brain—Alzheimer's disease	0.000419	0.00599	CbGeAlD
Orphenadrine—Dizziness—Memantine—Alzheimer's disease	0.000413	0.00852	CcSEcCtD
Orphenadrine—Nausea—Donepezil—Alzheimer's disease	0.000409	0.00843	CcSEcCtD
Orphenadrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000404	0.00834	CcSEcCtD
Orphenadrine—Vomiting—Memantine—Alzheimer's disease	0.000397	0.0082	CcSEcCtD
Orphenadrine—KCNH2—nervous system—Alzheimer's disease	0.000396	0.00566	CbGeAlD
Orphenadrine—Headache—Memantine—Alzheimer's disease	0.000391	0.00808	CcSEcCtD
Orphenadrine—Vomiting—Rivastigmine—Alzheimer's disease	0.000389	0.00802	CcSEcCtD
Orphenadrine—Headache—Rivastigmine—Alzheimer's disease	0.000383	0.0079	CcSEcCtD
Orphenadrine—KCNH2—central nervous system—Alzheimer's disease	0.000381	0.00545	CbGeAlD
Orphenadrine—KCNH2—cerebellum—Alzheimer's disease	0.000373	0.00533	CbGeAlD
Orphenadrine—Nausea—Memantine—Alzheimer's disease	0.000371	0.00766	CcSEcCtD
Orphenadrine—Nausea—Rivastigmine—Alzheimer's disease	0.000363	0.00749	CcSEcCtD
Orphenadrine—SLC6A2—brain—Alzheimer's disease	0.000337	0.00482	CbGeAlD
Orphenadrine—CYP2B6—nervous system—Alzheimer's disease	0.000325	0.00465	CbGeAlD
Orphenadrine—HRH1—nervous system—Alzheimer's disease	0.000318	0.00454	CbGeAlD
Orphenadrine—CYP2B6—central nervous system—Alzheimer's disease	0.000313	0.00447	CbGeAlD
Orphenadrine—HRH1—central nervous system—Alzheimer's disease	0.000306	0.00437	CbGeAlD
Orphenadrine—CYP2E1—nervous system—Alzheimer's disease	0.000305	0.00436	CbGeAlD
Orphenadrine—KCNH2—brain—Alzheimer's disease	0.000303	0.00433	CbGeAlD
Orphenadrine—CYP2E1—central nervous system—Alzheimer's disease	0.000294	0.0042	CbGeAlD
Orphenadrine—CYP2E1—cerebellum—Alzheimer's disease	0.000287	0.0041	CbGeAlD
Orphenadrine—Amitriptyline—NTRK2—Alzheimer's disease	0.000269	0.0468	CrCbGaD
Orphenadrine—Cyclopentolate—BCHE—Alzheimer's disease	0.000251	0.0437	CrCbGaD
Orphenadrine—CYP2B6—brain—Alzheimer's disease	0.000248	0.00355	CbGeAlD
Orphenadrine—CYP3A4—nervous system—Alzheimer's disease	0.000245	0.00351	CbGeAlD
Orphenadrine—HRH1—brain—Alzheimer's disease	0.000243	0.00347	CbGeAlD
Orphenadrine—CYP3A4—central nervous system—Alzheimer's disease	0.000236	0.00338	CbGeAlD
Orphenadrine—CYP2E1—brain—Alzheimer's disease	0.000233	0.00333	CbGeAlD
Orphenadrine—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000214	0.0372	CrCbGaD
Orphenadrine—Atomoxetine—HTR6—Alzheimer's disease	0.0002	0.0348	CrCbGaD
Orphenadrine—Reboxetine—SLC6A4—Alzheimer's disease	0.00019	0.0331	CrCbGaD
Orphenadrine—Toremifene—ESR1—Alzheimer's disease	0.000178	0.031	CrCbGaD
Orphenadrine—Promethazine—CALM1—Alzheimer's disease	0.000176	0.0306	CrCbGaD
Orphenadrine—Doxepin—HTR6—Alzheimer's disease	0.000157	0.0273	CrCbGaD
Orphenadrine—Ethopropazine—BCHE—Alzheimer's disease	0.000152	0.0265	CrCbGaD
Orphenadrine—Fenoprofen—PTGS1—Alzheimer's disease	0.000147	0.0255	CrCbGaD
Orphenadrine—Reboxetine—CYP2D6—Alzheimer's disease	0.000134	0.0233	CrCbGaD
Orphenadrine—Imipramine—HTR6—Alzheimer's disease	0.000122	0.0212	CrCbGaD
Orphenadrine—Amitriptyline—HTR6—Alzheimer's disease	0.000121	0.0211	CrCbGaD
Orphenadrine—Fluoxetine—SLC6A4—Alzheimer's disease	0.000119	0.0207	CrCbGaD
Orphenadrine—Mepyramine—CYP2D6—Alzheimer's disease	0.000119	0.0207	CrCbGaD
Orphenadrine—Tripelennamine—CYP2D6—Alzheimer's disease	0.00011	0.0192	CrCbGaD
Orphenadrine—Aprindine—CYP2D6—Alzheimer's disease	0.000108	0.0188	CrCbGaD
Orphenadrine—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.0001	0.0174	CrCbGaD
Orphenadrine—Fluoxetine—HTR2A—Alzheimer's disease	9.17e-05	0.0159	CrCbGaD
Orphenadrine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	9.17e-05	0.0159	CrCbGaD
Orphenadrine—Chlorphenamine—SLC6A4—Alzheimer's disease	9.12e-05	0.0159	CrCbGaD
Orphenadrine—Tolterodine—CYP2D6—Alzheimer's disease	8.79e-05	0.0153	CrCbGaD
Orphenadrine—Benzatropine—CYP2D6—Alzheimer's disease	8.46e-05	0.0147	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—Alzheimer's disease	8.39e-05	0.0146	CrCbGaD
Orphenadrine—Fluoxetine—CYP2D6—Alzheimer's disease	8.38e-05	0.0146	CrCbGaD
Orphenadrine—Atomoxetine—SLC6A4—Alzheimer's disease	7.66e-05	0.0133	CrCbGaD
Orphenadrine—Carbinoxamine—CYP2D6—Alzheimer's disease	7.54e-05	0.0131	CrCbGaD
Orphenadrine—Tamoxifen—ESR1—Alzheimer's disease	7.12e-05	0.0124	CrCbGaD
Orphenadrine—Brompheniramine—CYP2D6—Alzheimer's disease	6.53e-05	0.0114	CrCbGaD
Orphenadrine—Chlorphenamine—CYP2D6—Alzheimer's disease	6.41e-05	0.0112	CrCbGaD
Orphenadrine—Diphenhydramine—PTGS1—Alzheimer's disease	6.39e-05	0.0111	CrCbGaD
Orphenadrine—Trimipramine—SLC6A4—Alzheimer's disease	6.3e-05	0.011	CrCbGaD
Orphenadrine—Dextropropoxyphene—CYP2D6—Alzheimer's disease	6.19e-05	0.0108	CrCbGaD
Orphenadrine—Doxepin—SLC6A4—Alzheimer's disease	6.01e-05	0.0104	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—Alzheimer's disease	5.89e-05	0.0102	CrCbGaD
Orphenadrine—Atomoxetine—CYP2D6—Alzheimer's disease	5.39e-05	0.00937	CrCbGaD
Orphenadrine—Trimipramine—HTR2A—Alzheimer's disease	4.84e-05	0.00843	CrCbGaD
Orphenadrine—Imipramine—SLC6A4—Alzheimer's disease	4.68e-05	0.00813	CrCbGaD
Orphenadrine—Promethazine—HTR2A—Alzheimer's disease	4.66e-05	0.00811	CrCbGaD
Orphenadrine—Amitriptyline—SLC6A4—Alzheimer's disease	4.65e-05	0.00808	CrCbGaD
Orphenadrine—Doxepin—HTR2A—Alzheimer's disease	4.62e-05	0.00803	CrCbGaD
Orphenadrine—Trimipramine—CYP2D6—Alzheimer's disease	4.43e-05	0.00771	CrCbGaD
Orphenadrine—Diphenhydramine—CYP2D6—Alzheimer's disease	4.35e-05	0.00757	CrCbGaD
Orphenadrine—Promethazine—CYP2D6—Alzheimer's disease	4.27e-05	0.00742	CrCbGaD
Orphenadrine—Tamoxifen—CYP2D6—Alzheimer's disease	4.24e-05	0.00737	CrCbGaD
Orphenadrine—Doxepin—CYP2D6—Alzheimer's disease	4.22e-05	0.00734	CrCbGaD
Orphenadrine—Methadone—CYP2D6—Alzheimer's disease	4.2e-05	0.00731	CrCbGaD
Orphenadrine—Promazine—HTR2A—Alzheimer's disease	4.1e-05	0.00714	CrCbGaD
Orphenadrine—Imipramine—HTR2A—Alzheimer's disease	3.59e-05	0.00625	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—Alzheimer's disease	3.57e-05	0.00621	CrCbGaD
Orphenadrine—Imipramine—CYP2D6—Alzheimer's disease	3.29e-05	0.00571	CrCbGaD
Orphenadrine—Amitriptyline—CYP2D6—Alzheimer's disease	3.27e-05	0.00568	CrCbGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	1.41e-05	0.00011	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—Alzheimer's disease	1.4e-05	0.000109	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	1.39e-05	0.000109	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NPS—Alzheimer's disease	1.38e-05	0.000107	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.37e-05	0.000107	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6—Alzheimer's disease	1.36e-05	0.000106	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR6—Alzheimer's disease	1.36e-05	0.000106	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	1.35e-05	0.000106	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.35e-05	0.000105	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	1.34e-05	0.000105	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.33e-05	0.000104	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—AKT1—Alzheimer's disease	1.33e-05	0.000103	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—SST—Alzheimer's disease	1.31e-05	0.000102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GAB2—Alzheimer's disease	1.31e-05	0.000102	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.31e-05	0.000102	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	1.29e-05	0.000101	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	1.29e-05	0.000101	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	1.29e-05	0.000101	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—APP—Alzheimer's disease	1.28e-05	9.97e-05	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—AKT1—Alzheimer's disease	1.28e-05	9.96e-05	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—AKT1—Alzheimer's disease	1.28e-05	9.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.26e-05	9.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCL2—Alzheimer's disease	1.26e-05	9.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	1.26e-05	9.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.25e-05	9.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	1.24e-05	9.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSENEN—Alzheimer's disease	1.24e-05	9.65e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APH1A—Alzheimer's disease	1.22e-05	9.51e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	1.22e-05	9.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.21e-05	9.41e-05	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—Alzheimer's disease	1.21e-05	9.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	1.2e-05	9.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.19e-05	9.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NCSTN—Alzheimer's disease	1.19e-05	9.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	1.17e-05	9.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LRP1—Alzheimer's disease	1.16e-05	9.03e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CHAT—Alzheimer's disease	1.14e-05	8.92e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TPI1—Alzheimer's disease	1.14e-05	8.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	1.14e-05	8.89e-05	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6—Alzheimer's disease	1.13e-05	8.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GFAP—Alzheimer's disease	1.13e-05	8.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GAL—Alzheimer's disease	1.13e-05	8.82e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TPI1—Alzheimer's disease	1.12e-05	8.73e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CHAT—Alzheimer's disease	1.12e-05	8.73e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	1.11e-05	8.68e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	1.11e-05	8.68e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MAOB—Alzheimer's disease	1.1e-05	8.55e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.07e-05	8.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.06e-05	8.3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	1.06e-05	8.23e-05	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—Alzheimer's disease	1.05e-05	8.15e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.03e-05	8.06e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—A2M—Alzheimer's disease	1.02e-05	7.95e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1e-05	7.8e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—A2M—Alzheimer's disease	9.99e-06	7.78e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—A2M—Alzheimer's disease	9.97e-06	7.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	9.93e-06	7.74e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.83e-06	7.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	9.81e-06	7.65e-05	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—Alzheimer's disease	9.74e-06	7.59e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.68e-06	7.54e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSEN2—Alzheimer's disease	9.66e-06	7.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	9.51e-06	7.41e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	9.49e-06	7.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCR5—Alzheimer's disease	9.32e-06	7.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	9.17e-06	7.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.12e-06	7.11e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	9.05e-06	7.06e-05	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	8.98e-06	7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.97e-06	6.99e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PRKCG—Alzheimer's disease	8.93e-06	6.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NPY—Alzheimer's disease	8.89e-06	6.93e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	8.87e-06	6.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IAPP—Alzheimer's disease	8.84e-06	6.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	8.79e-06	6.85e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	8.77e-06	6.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	8.75e-06	6.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	8.69e-06	6.78e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ACHE—Alzheimer's disease	8.69e-06	6.77e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	8.68e-06	6.76e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	8.59e-06	6.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CRH—Alzheimer's disease	8.58e-06	6.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCR5—Alzheimer's disease	8.46e-06	6.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	8.44e-06	6.58e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	8.35e-06	6.51e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	8.33e-06	6.49e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	8.31e-06	6.48e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	8.31e-06	6.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—Alzheimer's disease	8.28e-06	6.45e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	8.15e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	8.15e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	8.14e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	8.14e-06	6.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NPS—Alzheimer's disease	8.13e-06	6.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PPP3CA—Alzheimer's disease	8.09e-06	6.31e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ND1—Alzheimer's disease	8.07e-06	6.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	8e-06	6.24e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—F2—Alzheimer's disease	7.99e-06	6.23e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	7.98e-06	6.22e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	7.97e-06	6.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	7.96e-06	6.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	7.87e-06	6.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	7.85e-06	6.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SST—Alzheimer's disease	7.76e-06	6.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	7.76e-06	6.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	7.76e-06	6.05e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	7.73e-06	6.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	7.73e-06	6.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	7.69e-06	5.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	7.63e-06	5.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	7.63e-06	5.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	7.63e-06	5.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	7.6e-06	5.93e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	7.57e-06	5.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	7.57e-06	5.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APP—Alzheimer's disease	7.56e-06	5.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	7.44e-06	5.8e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	7.29e-06	5.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—F2—Alzheimer's disease	7.26e-06	5.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	7.14e-06	5.57e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	7.14e-06	5.57e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	7.13e-06	5.56e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	7.07e-06	5.51e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	7.02e-06	5.47e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	6.92e-06	5.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	6.66e-06	5.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	6.61e-06	5.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	6.55e-06	5.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	6.51e-06	5.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	6.5e-06	5.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	6.47e-06	5.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	6.4e-06	4.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	6.37e-06	4.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S100B—Alzheimer's disease	6.15e-06	4.79e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	6.09e-06	4.75e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	6.06e-06	4.73e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	6.05e-06	4.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	5.97e-06	4.65e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	5.94e-06	4.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	5.85e-06	4.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	5.76e-06	4.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	5.66e-06	4.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	5.57e-06	4.34e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LPL—Alzheimer's disease	5.55e-06	4.32e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LPL—Alzheimer's disease	5.43e-06	4.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	5.43e-06	4.23e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.38e-06	4.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	5.34e-06	4.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	5.29e-06	4.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	5.27e-06	4.11e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.2e-06	4.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.2e-06	4.05e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	5.19e-06	4.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	5.14e-06	4.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	5.06e-06	3.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	5e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	4.99e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.98e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	4.92e-06	3.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.89e-06	3.81e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	4.89e-06	3.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	4.81e-06	3.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.8e-06	3.74e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	4.67e-06	3.64e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—Alzheimer's disease	4.65e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.63e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	4.61e-06	3.59e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	4.57e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.56e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—Alzheimer's disease	4.55e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.55e-06	3.54e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.55e-06	3.54e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	4.51e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.51e-06	3.51e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	4.49e-06	3.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	4.47e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	4.47e-06	3.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	4.43e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.34e-06	3.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.29e-06	3.34e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	4.27e-06	3.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	4.22e-06	3.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.2e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.13e-06	3.22e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	4.05e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.03e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.98e-06	3.11e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—INS—Alzheimer's disease	3.97e-06	3.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.97e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.94e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.91e-06	3.05e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—INS—Alzheimer's disease	3.89e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.88e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	3.88e-06	3.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	3.84e-06	3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	3.82e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.82e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.78e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.78e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.76e-06	2.93e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.76e-06	2.93e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.7e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.7e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.51e-06	2.74e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	3.48e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.41e-06	2.66e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.41e-06	2.66e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.35e-06	2.61e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.31e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.21e-06	2.5e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	3.19e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.12e-06	2.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.92e-06	2.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.89e-06	2.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.87e-06	2.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.87e-06	2.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.85e-06	2.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.83e-06	2.2e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.77e-06	2.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.76e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.66e-06	2.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.65e-06	2.07e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.62e-06	2.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.61e-06	2.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.52e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.45e-06	1.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.42e-06	1.88e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.27e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.25e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.22e-06	1.73e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.12e-06	1.65e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.11e-06	1.65e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.09e-06	1.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.85e-06	1.45e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.84e-06	1.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.82e-06	1.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.8e-06	1.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.7e-06	1.32e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.67e-06	1.3e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.6e-06	1.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.58e-06	1.23e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.57e-06	1.22e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.57e-06	1.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.54e-06	1.2e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.45e-06	1.13e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	7.27e-07	5.67e-06	CbGpPWpGaD
